N/A
N=802
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
Cervical Carcinoma · Human Papillomavirus Infection
Bottom Line
View on ClinicalTrials.gov: NCT04411849 ↗Enrolled (actual)
802
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Effectiveness of Human Papillomavirus (HPV) Intervention — 69; 17 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Best Practice (Other); HPV Self-Collection (Procedure); Informational Intervention (Other); Patient Navigation Program (Behavioral)
- Age
- Adult · 30+ yrs
- Sex
- Female
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Primary completion
- Jun 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Effectiveness of Human Papillomavirus (HPV) Intervention |
69; 17 | — |
Summary
This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.
Eligibility Criteria
Inclusion Criteria
- Not within recommended cervical cancer screening guidelines for women in this age range (i.e., no Papanicolaou [Pap] test in last 3 years or no Pap test plus clinic-based HPV test in last 5 years)
- Resident of an Appalachian county
- Not currently pregnant
- Intact cervix
- No history of invasive cervical cancer
- Seen in a participating clinic/health system in last 2 years (i.e., active patient)
- Have a working telephone
Data sourced from ClinicalTrials.gov (NCT04411849). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.